features of treatment of patients with diabetes mellitus type 2 with heart failure (literature review)
Clicks: 115
ID: 228775
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
115 views
11 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #67 of 79 articles by views in Macromolecular rapid communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Diabetes mellitus and heart failure are often comorbid conditions. The studies found that patients taking metformin as monotherapy (odds ratio 0.65 (0.48–0.87)) or in conjunction with other drugs (0.72 (0.59–0.90)), mortality rate is lower. Research results given in the survey confirm the efficacy of treatment for concomitant heart failure in patients with diabetes mellitus and show the benefits of using metformin to lower blood glucose levels in these patients.
| Reference Key |
pankiv2014mnarodnijfeatures
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;V.I. Pankiv |
| Journal | Macromolecular rapid communications |
| Year | 2014 |
| DOI |
10.22141/2224-0721.1.57.2014.76432
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.